The global market for Automation in Biopharmaceutical was estimated to be worth US$ 1008.7 million in 2023 and is forecast to a readjusted size of US$ 1588 million by 2030 with a CAGR of 6.2% during the forecast period 2024-2030

Automation in Biopharmaceutical - Market

The biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing RandD investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Automation in Biopharmaceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Automation in Biopharmaceutical by region & country, by Type, and by Application.

The Automation in Biopharmaceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automation in Biopharmaceutical.

Market Segmentation

Scope of Automation in Biopharmaceutical - Market Report

Report Metric	Details
Report Name	Automation in Biopharmaceutical - Market
Forecasted market size in 2030	US$ 1588 million
CAGR	6.2%
Forecasted years	2024 - 2030
Segment by Type:	Clinical Stage Automation Drug Discovery Stage Automation
Segment by Application	Research and Development Clinical
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Danaher, GE, PerkinElmer, Tecan Trading, Thermo Fisher Scientific, Bruker, Peak Analysis and Automation, Waters, Capsugel, RheoSense, Eirechrom, BioProcess International, Novasep
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Automation in Biopharmaceutical manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Automation in Biopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Automation in Biopharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Automation in Biopharmaceutical - Market size in 2030?

Ans: The Automation in Biopharmaceutical - Market size in 2030 will be US$ 1588 million.

Who are the main players in the Automation in Biopharmaceutical - Market report?

Ans: The main players in the Automation in Biopharmaceutical - Market are Danaher, GE, PerkinElmer, Tecan Trading, Thermo Fisher Scientific, Bruker, Peak Analysis and Automation, Waters, Capsugel, RheoSense, Eirechrom, BioProcess International, Novasep

What are the Application segmentation covered in the Automation in Biopharmaceutical - Market report?

Ans: The Applications covered in the Automation in Biopharmaceutical - Market report are Research and Development, Clinical

What are the Type segmentation covered in the Automation in Biopharmaceutical - Market report?

Ans: The Types covered in the Automation in Biopharmaceutical - Market report are Clinical Stage Automation, Drug Discovery Stage Automation

1 Market Overview

1.1 Automation in Biopharmaceutical Product Introduction

1.2 Global Automation in Biopharmaceutical Market Size Forecast

1.3 Automation in Biopharmaceutical Market Trends & Drivers

1.3.1 Automation in Biopharmaceutical Industry Trends

1.3.2 Automation in Biopharmaceutical Market Drivers & Opportunity

1.3.3 Automation in Biopharmaceutical Market Challenges

1.3.4 Automation in Biopharmaceutical Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Automation in Biopharmaceutical Players Revenue Ranking (2023)

2.2 Global Automation in Biopharmaceutical Revenue by Company (2019-2024)

2.3 Key Companies Automation in Biopharmaceutical Manufacturing Base Distribution and Headquarters

2.4 Key Companies Automation in Biopharmaceutical Product Offered

2.5 Key Companies Time to Begin Mass Production of Automation in Biopharmaceutical

2.6 Automation in Biopharmaceutical Market Competitive Analysis

2.6.1 Automation in Biopharmaceutical Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Automation in Biopharmaceutical Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automation in Biopharmaceutical as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Clinical Stage Automation

3.1.2 Drug Discovery Stage Automation

3.2 Global Automation in Biopharmaceutical Sales Value by Type

3.2.1 Global Automation in Biopharmaceutical Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Automation in Biopharmaceutical Sales Value, by Type (2019-2030)

3.2.3 Global Automation in Biopharmaceutical Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Research and Development

4.1.2 Clinical

4.2 Global Automation in Biopharmaceutical Sales Value by Application

4.2.1 Global Automation in Biopharmaceutical Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Automation in Biopharmaceutical Sales Value, by Application (2019-2030)

4.2.3 Global Automation in Biopharmaceutical Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Automation in Biopharmaceutical Sales Value by Region

5.1.1 Global Automation in Biopharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Automation in Biopharmaceutical Sales Value by Region (2019-2024)

5.1.3 Global Automation in Biopharmaceutical Sales Value by Region (2025-2030)

5.1.4 Global Automation in Biopharmaceutical Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Automation in Biopharmaceutical Sales Value, 2019-2030

5.2.2 North America Automation in Biopharmaceutical Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Automation in Biopharmaceutical Sales Value, 2019-2030

5.3.2 Europe Automation in Biopharmaceutical Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Automation in Biopharmaceutical Sales Value, 2019-2030

5.4.2 Asia Pacific Automation in Biopharmaceutical Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Automation in Biopharmaceutical Sales Value, 2019-2030

5.5.2 South America Automation in Biopharmaceutical Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Automation in Biopharmaceutical Sales Value, 2019-2030

5.6.2 Middle East & Africa Automation in Biopharmaceutical Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Automation in Biopharmaceutical Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Automation in Biopharmaceutical Sales Value

6.3 United States

6.3.1 United States Automation in Biopharmaceutical Sales Value, 2019-2030

6.3.2 United States Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Automation in Biopharmaceutical Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Automation in Biopharmaceutical Sales Value, 2019-2030

6.4.2 Europe Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Automation in Biopharmaceutical Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Automation in Biopharmaceutical Sales Value, 2019-2030

6.5.2 China Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

6.5.3 China Automation in Biopharmaceutical Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Automation in Biopharmaceutical Sales Value, 2019-2030

6.6.2 Japan Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Automation in Biopharmaceutical Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Automation in Biopharmaceutical Sales Value, 2019-2030

6.7.2 South Korea Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Automation in Biopharmaceutical Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Automation in Biopharmaceutical Sales Value, 2019-2030

6.8.2 Southeast Asia Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Automation in Biopharmaceutical Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Automation in Biopharmaceutical Sales Value, 2019-2030

6.9.2 India Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

6.9.3 India Automation in Biopharmaceutical Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Danaher

7.1.1 Danaher Profile

7.1.2 Danaher Main Business

7.1.3 Danaher Automation in Biopharmaceutical Products, Services and Solutions

7.1.4 Danaher Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.1.5 Danaher Recent Developments

7.2 GE

7.2.1 GE Profile

7.2.2 GE Main Business

7.2.3 GE Automation in Biopharmaceutical Products, Services and Solutions

7.2.4 GE Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.2.5 GE Recent Developments

7.3 PerkinElmer

7.3.1 PerkinElmer Profile

7.3.2 PerkinElmer Main Business

7.3.3 PerkinElmer Automation in Biopharmaceutical Products, Services and Solutions

7.3.4 PerkinElmer Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.3.5 Tecan Trading Recent Developments

7.4 Tecan Trading

7.4.1 Tecan Trading Profile

7.4.2 Tecan Trading Main Business

7.4.3 Tecan Trading Automation in Biopharmaceutical Products, Services and Solutions

7.4.4 Tecan Trading Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.4.5 Tecan Trading Recent Developments

7.5 Thermo Fisher Scientific

7.5.1 Thermo Fisher Scientific Profile

7.5.2 Thermo Fisher Scientific Main Business

7.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Products, Services and Solutions

7.5.4 Thermo Fisher Scientific Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.5.5 Thermo Fisher Scientific Recent Developments

7.6 Bruker

7.6.1 Bruker Profile

7.6.2 Bruker Main Business

7.6.3 Bruker Automation in Biopharmaceutical Products, Services and Solutions

7.6.4 Bruker Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.6.5 Bruker Recent Developments

7.7 Peak Analysis and Automation

7.7.1 Peak Analysis and Automation Profile

7.7.2 Peak Analysis and Automation Main Business

7.7.3 Peak Analysis and Automation Automation in Biopharmaceutical Products, Services and Solutions

7.7.4 Peak Analysis and Automation Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.7.5 Peak Analysis and Automation Recent Developments

7.8 Waters

7.8.1 Waters Profile

7.8.2 Waters Main Business

7.8.3 Waters Automation in Biopharmaceutical Products, Services and Solutions

7.8.4 Waters Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.8.5 Waters Recent Developments

7.9 Capsugel

7.9.1 Capsugel Profile

7.9.2 Capsugel Main Business

7.9.3 Capsugel Automation in Biopharmaceutical Products, Services and Solutions

7.9.4 Capsugel Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.9.5 Capsugel Recent Developments

7.10 RheoSense

7.10.1 RheoSense Profile

7.10.2 RheoSense Main Business

7.10.3 RheoSense Automation in Biopharmaceutical Products, Services and Solutions

7.10.4 RheoSense Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.10.5 RheoSense Recent Developments

7.11 Eirechrom

7.11.1 Eirechrom Profile

7.11.2 Eirechrom Main Business

7.11.3 Eirechrom Automation in Biopharmaceutical Products, Services and Solutions

7.11.4 Eirechrom Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.11.5 Eirechrom Recent Developments

7.12 BioProcess International

7.12.1 BioProcess International Profile

7.12.2 BioProcess International Main Business

7.12.3 BioProcess International Automation in Biopharmaceutical Products, Services and Solutions

7.12.4 BioProcess International Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.12.5 BioProcess International Recent Developments

7.13 Novasep

7.13.1 Novasep Profile

7.13.2 Novasep Main Business

7.13.3 Novasep Automation in Biopharmaceutical Products, Services and Solutions

7.13.4 Novasep Automation in Biopharmaceutical Revenue (US$ Million) & (2019-2024)

7.13.5 Novasep Recent Developments

8 Industry Chain Analysis

8.1 Automation in Biopharmaceutical Industrial Chain

8.2 Automation in Biopharmaceutical Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Automation in Biopharmaceutical Sales Model

8.5.2 Sales Channel

8.5.3 Automation in Biopharmaceutical Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Danaher

PerkinElmer Inc

Tecan Trading

Thermo Fisher Scientific

Bruker

Peak Analysis and Automation

BioProcess International

Novasep

List of Tables

Table 1. Automation in Biopharmaceutical Market Trends

Table 2. Automation in Biopharmaceutical Market Drivers & Opportunity

Table 3. Automation in Biopharmaceutical Market Challenges

Table 4. Automation in Biopharmaceutical Market Restraints

Table 5. Global Automation in Biopharmaceutical Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Automation in Biopharmaceutical Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Automation in Biopharmaceutical Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Automation in Biopharmaceutical Product Type

Table 9. Key Companies Time to Begin Mass Production of Automation in Biopharmaceutical

Table 10. Global Automation in Biopharmaceutical Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automation in Biopharmaceutical as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Automation in Biopharmaceutical Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Automation in Biopharmaceutical Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Automation in Biopharmaceutical Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Automation in Biopharmaceutical Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Automation in Biopharmaceutical Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Automation in Biopharmaceutical Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Automation in Biopharmaceutical Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Automation in Biopharmaceutical Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Automation in Biopharmaceutical Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Automation in Biopharmaceutical Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Automation in Biopharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Automation in Biopharmaceutical Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Automation in Biopharmaceutical Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Automation in Biopharmaceutical Sales Value by Region (2019-2024) & (%)

Table 27. Global Automation in Biopharmaceutical Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Automation in Biopharmaceutical Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Automation in Biopharmaceutical Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Automation in Biopharmaceutical Sales Value, (2025-2030) & (US$ Million)

Table 31. Danaher Basic Information List

Table 32. Danaher Description and Business Overview

Table 33. Danaher Automation in Biopharmaceutical Products, Services and Solutions

Table 34. Revenue (US$ Million) in Automation in Biopharmaceutical Business of Danaher (2019-2024)

Table 35. Danaher Recent Developments

Table 36. GE Basic Information List

Table 37. GE Description and Business Overview

Table 38. GE Automation in Biopharmaceutical Products, Services and Solutions

Table 39. Revenue (US$ Million) in Automation in Biopharmaceutical Business of GE (2019-2024)

Table 40. GE Recent Developments

Table 41. PerkinElmer Basic Information List

Table 42. PerkinElmer Description and Business Overview

Table 43. PerkinElmer Automation in Biopharmaceutical Products, Services and Solutions

Table 44. Revenue (US$ Million) in Automation in Biopharmaceutical Business of PerkinElmer (2019-2024)

Table 45. PerkinElmer Recent Developments

Table 46. Tecan Trading Basic Information List

Table 47. Tecan Trading Description and Business Overview

Table 48. Tecan Trading Automation in Biopharmaceutical Products, Services and Solutions

Table 49. Revenue (US$ Million) in Automation in Biopharmaceutical Business of Tecan Trading (2019-2024)

Table 50. Tecan Trading Recent Developments

Table 51. Thermo Fisher Scientific Basic Information List

Table 52. Thermo Fisher Scientific Description and Business Overview

Table 53. Thermo Fisher Scientific Automation in Biopharmaceutical Products, Services and Solutions

Table 54. Revenue (US$ Million) in Automation in Biopharmaceutical Business of Thermo Fisher Scientific (2019-2024)

Table 55. Thermo Fisher Scientific Recent Developments

Table 56. Bruker Basic Information List

Table 57. Bruker Description and Business Overview

Table 58. Bruker Automation in Biopharmaceutical Products, Services and Solutions

Table 59. Revenue (US$ Million) in Automation in Biopharmaceutical Business of Bruker (2019-2024)

Table 60. Bruker Recent Developments

Table 61. Peak Analysis and Automation Basic Information List

Table 62. Peak Analysis and Automation Description and Business Overview

Table 63. Peak Analysis and Automation Automation in Biopharmaceutical Products, Services and Solutions

Table 64. Revenue (US$ Million) in Automation in Biopharmaceutical Business of Peak Analysis and Automation (2019-2024)

Table 65. Peak Analysis and Automation Recent Developments

Table 66. Waters Basic Information List

Table 67. Waters Description and Business Overview

Table 68. Waters Automation in Biopharmaceutical Products, Services and Solutions

Table 69. Revenue (US$ Million) in Automation in Biopharmaceutical Business of Waters (2019-2024)

Table 70. Waters Recent Developments

Table 71. Capsugel Basic Information List

Table 72. Capsugel Description and Business Overview

Table 73. Capsugel Automation in Biopharmaceutical Products, Services and Solutions

Table 74. Revenue (US$ Million) in Automation in Biopharmaceutical Business of Capsugel (2019-2024)

Table 75. Capsugel Recent Developments

Table 76. RheoSense Basic Information List

Table 77. RheoSense Description and Business Overview

Table 78. RheoSense Automation in Biopharmaceutical Products, Services and Solutions

Table 79. Revenue (US$ Million) in Automation in Biopharmaceutical Business of RheoSense (2019-2024)

Table 80. RheoSense Recent Developments

Table 81. Eirechrom Basic Information List

Table 82. Eirechrom Description and Business Overview

Table 83. Eirechrom Automation in Biopharmaceutical Products, Services and Solutions

Table 84. Revenue (US$ Million) in Automation in Biopharmaceutical Business of Eirechrom (2019-2024)

Table 85. Eirechrom Recent Developments

Table 86. BioProcess International Basic Information List

Table 87. BioProcess International Description and Business Overview

Table 88. BioProcess International Automation in Biopharmaceutical Products, Services and Solutions

Table 89. Revenue (US$ Million) in Automation in Biopharmaceutical Business of BioProcess International (2019-2024)

Table 90. BioProcess International Recent Developments

Table 91. Novasep Basic Information List

Table 92. Novasep Description and Business Overview

Table 93. Novasep Automation in Biopharmaceutical Products, Services and Solutions

Table 94. Revenue (US$ Million) in Automation in Biopharmaceutical Business of Novasep (2019-2024)

Table 95. Novasep Recent Developments

Table 96. Key Raw Materials Lists

Table 97. Raw Materials Key Suppliers Lists

Table 98. Automation in Biopharmaceutical Downstream Customers

Table 99. Automation in Biopharmaceutical Distributors List

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Automation in Biopharmaceutical Product Picture

Figure 2. Global Automation in Biopharmaceutical Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Automation in Biopharmaceutical Sales Value (2019-2030) & (US$ Million)

Figure 4. Automation in Biopharmaceutical Report Years Considered

Figure 5. Global Automation in Biopharmaceutical Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Automation in Biopharmaceutical Revenue in 2023

Figure 7. Automation in Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Clinical Stage Automation Picture

Figure 9. Drug Discovery Stage Automation Picture

Figure 10. Global Automation in Biopharmaceutical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Automation in Biopharmaceutical Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Research and Development

Figure 13. Product Picture of Clinical

Figure 14. Global Automation in Biopharmaceutical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Automation in Biopharmaceutical Sales Value Market Share by Application, 2023 & 2030

Figure 16. North America Automation in Biopharmaceutical Sales Value (2019-2030) & (US$ Million)

Figure 17. North America Automation in Biopharmaceutical Sales Value by Country (%), 2023 VS 2030

Figure 18. Europe Automation in Biopharmaceutical Sales Value (2019-2030) & (US$ Million)

Figure 19. Europe Automation in Biopharmaceutical Sales Value by Country (%), 2023 VS 2030

Figure 20. Asia Pacific Automation in Biopharmaceutical Sales Value (2019-2030) & (US$ Million)

Figure 21. Asia Pacific Automation in Biopharmaceutical Sales Value by Country (%), 2023 VS 2030

Figure 22. South America Automation in Biopharmaceutical Sales Value (2019-2030) & (US$ Million)

Figure 23. South America Automation in Biopharmaceutical Sales Value by Country (%), 2023 VS 2030

Figure 24. Middle East & Africa Automation in Biopharmaceutical Sales Value (2019-2030) & (US$ Million)

Figure 25. Middle East & Africa Automation in Biopharmaceutical Sales Value by Country (%), 2023 VS 2030

Figure 26. Key Countries/Regions Automation in Biopharmaceutical Sales Value (%), (2019-2030)

Figure 27. United States Automation in Biopharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 28. United States Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 29. United States Automation in Biopharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 30. Europe Automation in Biopharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 31. Europe Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 32. Europe Automation in Biopharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 33. China Automation in Biopharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 34. China Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 35. China Automation in Biopharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 36. Japan Automation in Biopharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 37. Japan Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 38. Japan Automation in Biopharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 39. South Korea Automation in Biopharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 40. South Korea Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 41. South Korea Automation in Biopharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 42. Southeast Asia Automation in Biopharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 44. Southeast Asia Automation in Biopharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 45. India Automation in Biopharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 46. India Automation in Biopharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 47. India Automation in Biopharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 48. Automation in Biopharmaceutical Industrial Chain

Figure 49. Automation in Biopharmaceutical Manufacturing Cost Structure

Figure 50. Channels of Distribution (Direct Sales, and Distribution)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-17Q10023

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Pre-Clinical Chemistry Testing Device for Laboratory Animal Models Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-8U10163

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Fast-disintegrating Tablets Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-11I9951

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Immuno Oncology Assays Kit Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-34H832

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Automation in Biopharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-36Z5908

Automation in Biopharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Automation in Biopharmaceutical - Market Size

Automation in Biopharmaceutical - Market

Report Scope

Scope of Automation in Biopharmaceutical - Market Report

Chapter Outline

FAQ for this report

What is the Automation in Biopharmaceutical - Market size in 2030?

Who are the main players in the Automation in Biopharmaceutical - Market report?

What are the Application segmentation covered in the Automation in Biopharmaceutical - Market report?

What are the Type segmentation covered in the Automation in Biopharmaceutical - Market report?

FEATURED COMPANIES

RELATED REPORTS